and are expressed at very low or undetectable levels. 4 However, various cytokines, for example, interleukin [IL]-1, IL-6, and tumor necrosis factor [TNF]-α, are induced in the brain after tissue injury, cell death, or infection, and exert diverse actions. 4, 5 Cytokines can also cross the blood-brain barrier when a pathological condition occurs. Thus, the CNS can be affected by inflammatory mediators produced within the brain and also through the actions of mediators originating from the periphery. 5 There is mounting evidence that proinflammatory cytokines and chemokines are expressed (or detected) in the ischemic brain as well in patients with acute stroke and that they may play significant roles in the outcome of ischemic injury. 4, 6 Nonetheless, several studies have reported elevations of proinflammatory cytokines in peripheral blood [7] [8] [9] [10] [11] [12] as well as in cerebrospinal fluid in patients with ischemic stroke. 10, 13 S troke can be defined as focal cerebral damage caused by either vascular occlusion or rupture of vessels, with subsequent bleeding and neurological deficits. Stroke is a rare event in childhood, and several authors have estimated the incidence of stroke in children. 1, 2 The underlying basic mechanisms involved are not completely understood in stroke, although biochemical factors have been suggested. 3 Most inflammatory mediators have relatively few actions in healthy central nervous system (CNS) tissue
The aim of the authors is to examine the relationship between the cytokine levels that are thought to be involved in stroke etiopathogenesis (tumor necrosis factor [TNF]-α, interleukin [IL]-2, IL-6, IL-8, IL-11), soluble protein C receptor (sEPCR), and factor VIII (FVIII) levels. The study included 27 patients with stroke and 30 healthy controls, aged 0 to 18. In the comparison of the sEPCR, cytokine, and FVIII levels between patient and control groups, median levels of TNF-α, IL-2, IL-6, and IL-8 are found to be high in the patient group when compared with controls, whereas there is no difference in sEPCR, IL-11, and FVIII levels. In the patient group, a positive correlation is seen between TNF-α levels and IL-2 and IL-6 levels, between IL-2 and IL-6 levels, and between IL-6 and IL-8 levels, whereas a negative relationship is seen between sEPCR and FVIII. In the control group apart from the patient group, a negative relationship is seen between TNF-α and FVIII, whereas there is a positive relationship between IL-11 and sEPCR levels. Median sEPCR levels in patients who have normal or low FVIII levels are significantly high when compared with those with high FVIII levels. In conclusion, in the pediatric population, an increase in TNF-α, IL-2, IL-6, and IL-8 levels is seen. Also, an inverse relationship of sEPCR and FVIII levels is shown for the first time. This study provides a basis for ongoing studies that aim to clarify stroke etiopathogenesis. Studies with larger series of patients are warranted to confirm this hypothesis.
Keywords: pediatric stroke; sEPCR levels; factor VIII; cytokine; TNF-α; interleukin
It is worth noting that all the published data are for patients above 18 years of age.
The protein C pathway is a crucial mechanism for the regulation of coagulation. The endothelial protein C receptor (EPCR) was identified in the protein C system. 14 Increased levels of soluble protein C receptor (sEPCR) in plasma lead to dysfunction of the EPCR-mediated coagulation. 15, 16 Elevated sEPCR levels are found in patients with sepsis and systemic lupus erythematosus, conditions associated with considerable thrombin production and coagulopathy. 17 Saposnik et al 18 reported that a specific haplotype of the EPCR gene (A3) is associated with increased plasma sEPCR levels and is a candidate risk factor for venous thrombosis. Uitte de Willige et al 19 showed that none of the haplotypes of the EPCR gene is associated with an increased risk of thrombosis, but low sEPCR levels appear to reduce the risk of deep vein thrombosis. Our previous study had demonstrated for the first time that elevated sEPCR levels increase the risk of stroke at pediatric age. 20 In vitro studies of endothelial cells have shown that both thrombomodulin (TM) and EPCR are downregulated by inflammatory cytokines, including TNF 21 and IL-1β. 22 Factor VIII (FVIII) is a plasma glycoprotein that is produced by the liver. It is known that the coagulant activity of FVIII is increased as an acute phase reaction in pregnancy, malignancy, during the use of oral contraceptives, in thrombosis, and in conditions that lead to hypoxia. 23 Recently, it was reported that increased FVIII levels are an important risk factor for venous and arterial thrombosis. 24, 25 The possible mechanisms that are thought to be responsible for elevated FVIII levels include an increase in thrombin formation and acquired activated protein C resistance, but the underlying mechanisms are not yet clearly understood. [25] [26] [27] [28] The physiological importance and influence of sEPCR levels in vivo and its relation to cytokines and FVIII as regards stroke are still unknown. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and be critical for the development of effective therapies for CNS diseases. The aim of our study is to examine the relation between cytokines (TNF-α, IL-2, IL-6, IL-8) that are thought to be involved in stroke etiopathogenesis and sEPCR and FVIII levels.
Materials and Methods

Sample Collection, Controls, and Cases
A total of 27 pediatric stroke patients (13 boys, 14 girls) admitted to our Pediatric Neurology Department and 30 healthy controls (13 boys, 17 girls) were evaluated in this study. The mean age of the patients was 4.5 (0.1 to 18) years. The patients were diagnosed with ischemic cerebral infarct using both CT scanning and magnetic resonance imaging techniques. The control group consisted of 30 healthy individuals who did not develop thrombosis to date. The mean age of the controls was 4 (0.7 to 16) years. Informed consent was obtained from all parents. Our local ethics committee approved the study.
The age of onset of stroke symptoms was between newborn and 16 years. The neurological findings were as follows: hemiparesis in 21 (77.8%), aphasia in 3 (11.1%), seizure in 21 (77.8%), headache in 3 (11.1%), and cranial nerve involvement in 7 (25.9%) patients. Stroke lesions were unilateral in 18 and bilateral in 9 patients. The hemispheric localizations of these lesions were temporoparietal (9 patients), occipital (5 patients), frontotemporoparietal (4 patients), temporoparieto-occipital (3 patients), basal ganglial (2 patients), panhemispheric (2 patients), and at the sinus veins (1 patient). One patient with an occipital lesion had accompanying vascular cognitive impairment (VCI) and right renal artery involvement. In the follow-up period 1 patient developed a second stroke attack (patient 3), 4 patients developed epilepsy, and 1 patient, autism; 1 patient was lost to follow-up, and 5 patients died.
Blood samples were collected by venipuncture in tubes containing 0.11 M sodium citrate at least 6 months after the first stroke attack. Platelet-poor plasma was obtained by centrifugation at 2000×g for 20 minutes and stored at −80°C until use. Cytokine (IL-2, IL-6, IL-8, IL-11, TNF-α), FVIII, and sEPCR levels were analyzed in the patient and control groups.
Cytokine Level Measurement
In both groups, cytokine levels were analyzed using automated multiplex serum cytokine assays (Luminex Corporation, USA). Cytokine (IL-2, IL-6, IL-8, IL-11, TNF-α) levels of the patient group were measured 6 months from the first episode of stroke. IL-11 levels were analyzed by human IL-11 immunoassay (Quantikine R&D Systems, USA).
sEPCR Assay
Soluble EPCR levels were determined in plasma using sEPCR Asserachrom enzyme-linked immunosorbent assay (ELISA) kits from Diagnostica Stago (Asnières, France), according to the manufacturer's instructions. Samples were assayed in duplicate. Plasma sEPCR levels of the patient group were measured 6 months from the first episode of stroke. Pediatric stroke patients with neonatal onset were evaluated for sEPCR after age 1. Plasma levels of 100 ng/mL and below were accepted to be normal according to our laboratory's standards.
Measurement of Factor VIII Level
FVIII levels were measured concomitantly with one stage factor assay method and FVIII-absent plasma (Sigma Diagnostics Inc, St Louis, MO). If plasma FVIII levels were beyond the cutoff level (>150 IU/dL), this was accepted as "high."
Statistical Analysis
Statistical analyses were performed using SPSS for Windows, version 11.5. Categorical data were summarized as frequencies and percentages. Continuous data were summarized as medians (minimum, maximum). For statistical analysis, the chi-square test and Mann-Whitney test were used as appropriate. Nonparametric analyses were used throughout because the inflammatory markers were not normally distributed. The relationship between inflammatory markers, sEPCR, and FVIII was determined using Spearman's rank correlation.
Results
There were no differences between patients and the control group as regards age and gender distribution (P values were .27 and .5, respectively). The sEPCR, cytokine (TNF-α, IL-2, IL-6, IL-8, IL-11), and FVIII levels of the patient and control groups were compared using the Mann-Whitney test ( Table 1 ). The TNF-α, IL-2, IL-8, and IL-6 median levels of the patient group were found to be increased when compared with the control group (P values were 0, 0, 0, and .005, respectively). The sEPCR, IL-11, and FVIII median levels were not different between the 2 groups (P values were .911, .672, and .890, respectively; Table 1 ).
The association of plasma cytokine (TNF-α, IL-2, IL-6, IL-8, IL-11), sEPCR, and FVIII levels in the patient and control groups was analyzed using the nonparametric correlation test. In the patient group, a positive correlation was found between TNF-α and IL-2 (r = 0.956, P = 0) and IL-6 (r = 0.412, P = .03) levels, between IL-2 and IL-6 levels (r = 0.384, P = .048), and between IL-6 and IL-8 levels (r = 0.867, P = 0). No relationship was found between IL-11 and other cytokine, sEPCR, and FVIII levels. A negative relationship with sEPCR was found only between FVIII levels (r = −0.491, P = .009; Table 2 ). In the control group, apart from the patient group, a negative relationship with TNF-α was found only between FVIII levels (r = −0.540, P = .002). A positive relationship with IL-2 was found only between IL-6 levels (r = 0.393, P = .032), and a positive relationship with IL-6 was found between IL-8 levels (r = 0.695, P = 0). Similar to the patient group, no relationship was found between IL-11 and other cytokine or FVIII Cytokines, sEPCR, and FVIII in Pediatric Stroke / Yürürer et al 547 levels in the control group. However, in contrast to the situation in the patient group, in the control group, a positive relationship with sEPCR was found (r = 0.431, P = .017; Tables 2 and 3 ).
In the patient group, median levels of sEPCR and cytokines (TNF-α, IL-2, IL-6, IL-8, IL-11) were compared with FVIII levels using the Mann-Whitney test. The median sEPCR level was significantly high in the group in which the levels of FVIII were normal or low (n = 11) as compared with the group in which FVIII levels were found to be high (n = 16; for sEPCR, P = .03 < .05). For FVIII levels, no significant differences were found between median values of cytokine (TNF-α, IL-2, IL-6, IL-8, IL-11) levels (P values were .61, .64, .9, .64, and .97, respectively).
In the patient group, median values of FVIII and cytokine (TNF-α, IL-2, IL-6, IL-8, IL-11) levels were compared according to sEPCR levels using the Mann-Whitney test. The median FVIII levels were significantly high in the group in which the levels of sEPCR were normal or low (n = 15) as compared with the group in which the FVIII levels were high (n = 15; for sEPCR, .016 < .05). There was no significant difference between the median values of cytokine (TNF-α, IL-2, IL-6, IL-8, IL-11) levels (P values were .79, .34, .68, .3, and .89, respectively).
Discussion
There are several studies on the cytokine levels in adult stroke patients However, as pediatric stroke is arterial in origin, determining the cytokine levels in the first few hours would not be easy in the pediatric population. The coagulation system can be evaluated in thrombotic cases after a certain amount time (eg, 6 months). Therefore, in pediatric stroke patients, this study was planned just like it is performed in thrombosis patients.
We recall the studies of Saposnik et al 18 and Willige et al 19 discussed in the introduction, where we also mentioned that in vitro studies of endothelial cells have shown that both TM and EPCR are downregulated by inflammatory cytokines, including TNF 21 and IL-1β. 22 The activation of the inflammatory cytokines that are involved in the etiopathogenesis of stroke may reduce the anti-inflammatory and anticoagulant effect of activated protein C and increase the release of sEPCR. In our study, we analyzed the differences and the correlation of FVIII, an independent risk factor in the poststroke period, [23] [24] [25] cytokines (TNF-α, IL-1β, IL-2, IL-6, IL-8), and sEPCR, which was reported to be high in nonpediatric stroke events, 4, 20, [29] [30] [31] [32] and the levels of IL-11 that may be involved in stroke physiopathology. In the comparison of the sEPCR, cytokine, and FVIII levels between patient and control groups, median levels of TNF-α, IL-2, IL-6, and IL-8 were found to be high in the patient group when compared with the control group, whereas sEPCR, IL-11, and FVIII median levels did not differ between the 2 groups ( Table 2) . For the first time, we were able to demonstrate the possible role of TNF-α, IL-2, IL-6, and IL-8 in stroke pathophysiology in children.
Furthermore, we demonstrated, for the first time, high plasma levels of TNF-α, IL-2, IL-6, and IL-8 after 6 months of the acute attack. Our results seem to be contradictory to those in the study that reports an increase in IL-6 plasma levels and a decrease in IL-2 levels at acute cerebral infarcts in nonpediatric cases, and our results reflect a chronic period. 29 In an earlier adult study, Grau et al 31 found that patients with ischemic stroke at young age possess a persistently increased capacity to release the IL-8 and tend to have an enhanced release of TNF-α and IL-6 on stimulation with lipopolysaccharide 5 years after the stroke.
The mechanisms that control the expression of different cytokines are often related: TNF-α stimulates the expression of IL-1 and IL-6, and IL-1 can induce both IL-6 and TNF-α. 5 With our data we were able to confirm the previous data through demonstration of positive correlations between TNF-α and IL-2 and IL-6 levels, between IL-2 and IL-6 levels, and between IL-6 and IL-8 levels.
IL-11 is a cytokine that was not studied previously in stroke ethiopathogenesis, but it has a known anti-inflammatory effect with proinflammatory gene expression inhibition 25, 26 and effect on hematopoetic and nonhematopoetic cell types. 33 IL-1 and TNF-α induce the protein secretion and/or gene expression of IL-11. 34 Nakchbandi and Mitnick 35 reported in their study that increase in IL-6 production in response to parathormone decreases the IL-11 production and plasma IL-11 levels via downregulation. In a rat experiment, it was reported that rhIL-11 increases the vWf/FVIII levels. 36 IL-11 may cause stroke by increasing the FVIII level, and it may affect the prognosis via an anti-inflammatory effect. However, we were not able to show a relation between IL-11 and other cytokines, sEPCR, and FVIII. The IL-11 levels were not elevated in our patients, so we were not able to show its effect on TNF-α, IL-6, IL-2, and FVIII levels. Cytokines, sEPCR, and FVIII Furthermore, we were able to demonstrate a negative relationship between sEPCR and FVIII, suggesting that the association of sEPCR and FVIII makes them regulate the action of each other, and this association may play a role in the stroke pathophysiology. This needs further study. Ulu et al 37 described an association between sEPCR and TNFα in healthy nonpediatric controls.
A better understanding of the parameters that are involved in stroke pathogenesis may help us in predicting the prognosis and suggesting new therapies, although more detailed studies are required.
